{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:07:57Z","timestamp":1748664477322,"version":"3.41.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:p>The literature regarding <jats:italic toggle=\"yes\">Clostridioides difficile<\/jats:italic> infection (CDI) in left ventricular assist devices (LVADs) patients is limited. Therefore, we aimed to characterize the clinical course, risk factors, management, and outcomes of LVAD patients who developed CDI. Adult patients who underwent LVAD placement during 2010\u20132022 and developed CDI were included. To determine risk factors and outcomes, we matched CDI patients with LVAD patients who did not develop CDI. Each CDI case was matched with up to two control subjects by age, sex, and time from LVAD implantation. Forty-seven of 393 LVAD patients (12.0%) developed CDI. The median time from LVAD implantation to CDI was 147 days (interquartile range 22.5\u2013647.0). The most common CDI treatment was oral vancomycin (n = 26, 55.3%). Thirteen patients (27.7%) required treatment extension because of a lack of clinical response. Three patients (6.4%) developed recurrent CDI. When 42 cases were matched to 79 control subjects, antibiotic exposure within 90 days was significantly associated with CDI (adjusted odds ratio 5.77; 95% confidence interval, 1.87\u201317.74; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.002). Moreover, CDI was associated with 1 year mortality (adjusted hazard ratio 2.62; 95% confidence interval, 1.18\u20135.82; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.018). This infection occurs most often within the first year after LVAD implantation and was associated with 1 year mortality. Antibiotic exposure is an important risk for CDI.<\/jats:p>","DOI":"10.1097\/mat.0000000000002008","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T15:37:21Z","timestamp":1687880241000},"page":"950-955","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Characteristics and Outcomes of Clostridioides difficile Infection in Patients With Left Ventricular Assist Device"],"prefix":"10.1097","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3507-6411","authenticated-orcid":false,"given":"Supavit","family":"Chesdachai","sequence":"first","affiliation":[{"name":"Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary A.","family":"Yetmar","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria A.","family":"Mendoza","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nischal","family":"Ranganath","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah D.","family":"Schettle","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry A.","family":"Boilson","sequence":"additional","affiliation":[{"name":"Department of Advanced Heart Failure, Transplant, and LVAD, Mayo Clinic, Rochester, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya S.","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymund R.","family":"Razonable","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,6,27]]},"reference":[{"key":"R1-20250530","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","article-title":"Global public health burden of heart failure.","volume":"3","author":"Savarese","year":"2017","journal-title":"Card Fail Rev"},{"key":"R2-20250530","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.jacc.2013.05.020","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines.","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R3-20250530","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.","volume":"70","author":"Yancy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R4-20250530","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term use of a left ventricular assist device for end-stage heart failure.","volume":"345","author":"Rose","year":"2001","journal-title":"N Engl J Med"},{"key":"R5-20250530","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.2022.16197","article-title":"Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 Randomized Trial.","volume":"328","author":"Mehra","year":"2022","journal-title":"JAMA"},{"key":"R6-20250530","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/CIRCULATIONAHA.107.691972","article-title":"Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era.","volume":"116","author":"Lietz","year":"2007","journal-title":"Circulation"},{"key":"R7-20250530","doi-asserted-by":"crossref","first-page":"ofaa124","DOI":"10.1093\/ofid\/ofaa124","article-title":"In full flow: Left ventricular assist device infections in the modern era.","volume":"7","author":"Zinoviev","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"R8-20250530","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.athoracsur.2010.04.093","article-title":"Infectious complications in patients with left ventricular assist device: Etiology and outcomes in the continuous-flow era.","volume":"90","author":"Topkara","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"R9-20250530","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.healun.2011.01.717","article-title":"Working formulation for the standardization of definitions of infections in patients using ventricular assist devices.","volume":"30","author":"Hannan","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R10-20250530","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10096-019-03539-6","article-title":"Clostridium difficile infection: Review.","volume":"38","author":"Czepiel","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"suppl 3","key":"R11-20250530","article-title":"Clostridium difficile Infection in Patients with a Continuous Flow, Durable Left Ventricular Assist Device.","volume":"16","author":"Glick Frasiolas","year":"2016","journal-title":"Am J Transplant"},{"key":"R12-20250530","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners.","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"R13-20250530","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R14-20250530","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R15-20250530","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1017\/S0899823X00193857","article-title":"Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update.","volume":"35","author":"Dubberke","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R16-20250530","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the infectious diseases Society of America (IDSA).","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R17-20250530","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1012413","article-title":"Host and pathogen factors for Clostridium difficile infection and colonization.","volume":"365","author":"Loo","year":"2011","journal-title":"N Engl J Med"},{"key":"R18-20250530","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1053\/j.gastro.2014.01.059","article-title":"Role of the intestinal microbiota in resistance to colonization by Clostridium difficile.","volume":"146","author":"Britton","year":"2014","journal-title":"Gastroenterology"},{"key":"R19-20250530","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.healun.2020.02.004","article-title":"Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant.","volume":"39","author":"Yuzefpolskaya","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R20-20250530","doi-asserted-by":"crossref","first-page":"e007909","DOI":"10.1161\/CIRCHEARTFAILURE.120.007909","article-title":"Levels of trimethylamine N-oxide remain elevated long term after left ventricular assist device and heart transplantation and are independent from measures of inflammation and gut dysbiosis.","volume":"14","author":"Yuzefpolskaya","year":"2021","journal-title":"Circ Heart Fail"},{"key":"R21-20250530","doi-asserted-by":"crossref","first-page":"S249","DOI":"10.1016\/j.healun.2016.01.708","article-title":"Intestinal microbiota changes in left ventricular assist device supported patients with gastrointestinal bleeding.","volume":"35","author":"Loyaga-Rendon","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"R22-20250530","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.athoracsur.2020.12.038","article-title":"The Society of Thoracic Surgeons Intermacs 2020 Annual Report.","volume":"111","author":"Molina","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"R23-20250530","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1093\/cid\/ciab549","article-title":"Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults.","volume":"73","author":"Johnson","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"4, Supplement","key":"R24-20250530","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1016\/j.healun.2022.01.1022","article-title":"Fecal transplant for recurrent Clostridium difficile colitis in CF-LVAD supported patients.","volume":"41","author":"Schettle","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"R25-20250530","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/MAT.0000000000000684","article-title":"Left ventricular assist device infections: A systematic review.","volume":"64","author":"O\u2019Horo","year":"2018","journal-title":"ASAIO J"}],"container-title":["ASAIO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MAT.0000000000002008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T13:06:03Z","timestamp":1748610363000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MAT.0000000000002008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,27]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mat.0000000000002008","relation":{},"ISSN":["1058-2916"],"issn-type":[{"type":"print","value":"1058-2916"}],"subject":[],"published":{"date-parts":[[2023,6,27]]}}}